A core human gut microbe, , produces a broad-spectrum bacteriocin mediterrocin.

UNLABELLED

A diverse, stable community of microbes in the human gut is strongly tied to health. The factors that regulate microbial community structure and dynamics are ill-defined. In this study, we discover mediterrocin, a bacteriocin produced by the core member of the human gut microbiota, (previously ). Following a screen for antimicrobial production by clinical isolates of , mediterrocin was isolated by bioactivity-guided fractionation from strain RJX1121, identified by mass spectrometry, and confirmed by gene disruption. Mediterrocin, an 89 amino acid secreted protein, is a broad-spectrum bacteriocin. Annotation of the mediterrocin biosynthetic gene cluster revealed a wide distribution among Bacillota (previously Firmicutes), including the type strain ATCC249149. The type strain of also produces mediterrocin, but in lower titers than RJX1121 under our culture conditions. Mediterrocin is inhibitory to multiple strains, but with varying sensitivity, with isolates from patients with inflammatory bowel disease displaying the greatest susceptibility. Beyond , mediterrocin demonstrated inhibitory activity against other Lachnospiraceae and the gram-negative pathogen . Further characterization of mediterrocin may clarify how this core member of the healthy microbiome interacts with other community members and how the relative abundance of changes in microbiome dysbiosis associated with several diseases.

IMPORTANCE

is a core member of the gut microbiome and implicated in several diseases. Direct competition between and other members of the microbiome may contribute to the shift from a diverse, structured community to dysbiosis observed in disease. Identifying molecular mechanisms of microbial competition will aid future studies of these disease-relevant bacteria and clarify how community structure is maintained. We report the discovery of mediterrocin, a bacteriocin present in many species in the orders Lachnospirales and Eubacteriales, but clade-specific within . Mediterrocin, produced by health-associated strains of , inhibits the growth of disease-associated strains and a broad spectrum of gut commensal bacteria and pathogens.